Primary Care POC Diagnostics Market Size to Reach USD 9.5 Billion in 2028, Says Reports and Data

Shift in diagnostics from centralized labs toward practitioners’ offices to drive market growth.

The global primary care POC diagnostics market size is expected to reach USD 9.5 billion in 2028 registering a CAGR of 3.4% over the forecast period, according to the latest report by Reports and Data. Major factor driving market revenue growth is paradigm shift in diagnostics from centralized labs toward practitioners’ offices.

Point-of care tests (POCTs) are defined as laboratory services using small analytical devices that test blood, saliva, urine, and faeces, conducted in a patient consultation setting rather than in a traditional central laboratory. POCTs are useful in primary care, as demonstrated by studies conducted in Europe.

Primary care POC diagnostics market players have been continually launching new products, which has attributed to its growth. For instance, Roche Diagnostics unveiled Roche v-TAC in May 2020, a point-of-care (POC) device that enables clinicians to obtain results for arterial blood gas values from patients with respiratory anomalies using a software algorithm and a less invasive venous puncture.

Abbott Laboratories announced in March 2020 a point-of-care test that will provide quick results in a wide variety of healthcare environments, including physician's offices and urgent care clinics, with positive results available in five minutes.

In 2021, the federal Food and Drug Administration (FDA) announced that it has granted a CLIA waiver for the binx health io CT/NG assay. This is a point-of-care diagnostic test that will be made available for use in physician’s offices, urgent care clinics, and other healthcare settings. It is molecular platform that will help in the diagnosis and management of chlamydia and gonorrhoea.

Other companies are undertaking acquisitions to enter the primary care POC diagnostics market. For instance, Thermo Fisher Scientific purchased Mesa Biotech, a supplier of point-of-care diagnostics, for USD 450 million in cash in January 2021 with the goal of developing potential point-of-care monitoring instruments for infectious diseases and accelerating the availability of reliable advanced diagnostics at primary care centres.

Access Free sample PDF Copy of the Report @

Some Key Highlights in the Report:

  • The glucose testing segment accounted for largest market share in 2020. Increasing adoption of glucose monitoring devices, expanding diabetic population, and growing awareness about keeping glucose level in check are factors that will drive the segment’s revenue growth.
  • Physician’s office segment accounted for largest revenue share among the end use segments in 2020.
  • Pharmacy and retail clinics segment is expected to be another fastest-growing segment. Segment growth is attributed to factors such as increasing volume of patients needing chronic disease tests at pharmacies and growing availability of point-of-care testing at pharmacies and retail clinics.
  • The market revenue from North America primary care POC diagnostics market is expected to grow at a significantly high rate over the forecast period due to presence of major market players in the region.
  • Asia Pacific region is expected to hold considerable revenue share due initiatives taken by several governments for  better access to primary care and the integration of POC diagnostics into primary care settings.
  • Some of the prominent players in the primary care POC diagnostics market include Roche Diagnostics, BD Biosciences, Danaher Corporation, Abbott Laboratories, Instrumentation Laboratory, bioMerieux, Siemens Healthcare, and Quidel Corporation.

Buy now your Exclusive copy of Report @

Segments covered in the report:

For the purpose of this report, Reports and Data has segmented the global primary care POC diagnostics market on the basis of product, end use and region:

Product Outlook (Revenue, USD Million; 2018 – 2028)


  • Glucose Testing
  • Hb1Ac Testing
  • Coagulation
  • Fertility
  • Infectious Diseases
  • Cardiac Markers
  • Thyroid Stimulating Hormone
  • Hematology
  • Primary Care Systems
  • Decentralized Clinical Chemistry
  • Feces
  • Lipid Testing
  • Cancer Marker
  • Blood Gas/Electrolytes
  • Ambulatory Chemistry
  • Drug Abuse Testing
  • Urinalysis

Request for Custom Research @

By End Use Outlook (Revenue, USD Million; 2018 – 2028)

  • Pharmacy & Retail Clinics
  • Physician Office
  • Urgent Care Clinics
  • Non-practice Clinics

Region Outlook (Revenue, USD Billion; 2018 – 2028)

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of Middle East & Africa

Explore Reports and Data's Prime Analysis of the global Pharmaceutical & Healthcare Industry:

Oligonucleotide Synthesis Market by Type (Reagents & Consumables, Equipment, Synthesized oligonucleotides, DNA oligonucleotides, RNA oligonucleotides, And Others), By Application Type (Research, Polymerase Chain Reaction, Next Generation Sequencing, Therapeutics, Antisense Oligonucleotides, Nucleic Acid Aptamers, Diagnostics), And Region-Global Forecast To 2027

Nanomedicine Market Analysis By Products (Therapeutics, Regenerative Medicine, In-vitro diagnostics, In-vivo diagnostic, Vaccines), By Drug Delivery System (Nanobots, Nanoghosts, Nanoclusters, Nanobubbles, Exosomes, Injectable Nanoparticle Generator, Dendrimers, Liposomes, Carbon nanotube, Graphene, Others), By Application (Oncology, Infectious diseases, Cardiology, Orthopedics, Others) And Segment Forecasts to 2027

Virtual Reality in Healthcare Market Analysis By Technology (Full Immersive, Non-Immersive, Semi-Immersive), By Component (Hardware, Software), By Application (Patient Care Management, Education & Training, Fitness Management, Pharmacy Management, Surgery), By End User (Research and Diagnostics, Laboratories, Hospitals & Clinics, Research Organizations, Pharmaceutical Companies), By Device Type (Head-Mounted Display, Gesture-Tracking Device, Projectors And Display Units, Others), By Region, Segment Forecasts To 2027

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web:

Direct Line: +1-212-710-1370


Read Full Press Release:

Back to news